Concourse Financial Group Securities, Inc. Mainz Biomed N.V. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MYNZ
# of Institutions
10Shares Held
103KCall Options Held
0Put Options Held
0-
Northern Trust Corp Chicago, IL29.9KShares$7,4830.0% of portfolio
-
Vontobel Holding Ltd.25KShares$6,2500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.2KShares$3,7970.0% of portfolio
-
Xtx Topco LTD London, X011.4KShares$2,8390.0% of portfolio
-
Greenwich Investment Management, Inc. Stamford, CT10.9KShares$2,7140.0% of portfolio
About MAINZ BIOMED N.V.
- Ticker MYNZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 14,483,000
- Market Cap $3.62M
- Description
- Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...